A new publication in Nature Reviews Methods Primers provides essential guidance for conducting rigorous systematic reviews on ...

With only 12% 1 of therapies surviving the gauntlet of Phase III trials to receive FDA approval, and the cost to bring a drug ...

Pharma leaders need to consider the lack of diversity in clinical trial findings and the resulting dearth of therapies ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about ...

Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often ...

This is the fifth edition of our blog series on decentralized clinical trials DCTs. Click here to explore the series. The ...

F or those of us who have not yet participated in a clinical trial, it may feel like unfamiliar territory. However, ...

In this interview, NewsMedical talks to Cerba's Lukasz Wulnikowski about the power of automation and how it has drastically ...

Dr. Clifford Yut shares how Houstonians can participate in clinical research and groundbreaking clinical trials.

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whether to participate in cancer trials, according to surveys of patients ...

After a six-month beta testing period, the European Clinical Trials Information Network is rolling out its patient ...